Population
Health
DeepHealth Brain
Assess and monitor neurodegenerative changes with quantitative and reference
data
DeepHealth Brain is an AI-powered clinical imaging solution for brain atrophy quantification and white
matter hyperintensities (WMH) detection. It supports the assessment and monitoring of neurodegenerative
changes with quantitative and reference data. FDA-cleared and CE-marked, DeepHealth Brain seamlessly
integrates into existing workflows, with results, reports, and segmentations exported directly to PACS.
It offers flexible deployment options, including on-site or cloud-based installation.
Book a demo
“Using DeepHealth Brain enables us to provide
our
clinicians with valuable objective information derived from our MRI scans. Comparing the
patient's results to a non-biased reference population makes it easier for clinicians to
give patients insights into their atrophy development.”
Mario Muto
Director Diagnostic and Interventional Neuroradiology unit at
Cardarelli Hospital, Naples
“During our MDT meetings, we always pull up
the report from DeepHealth Brain and use it as extra information to come to a joint
decision
on the best diagnosis and clinical management of the patient.“
Meike Vernooij
Professor of Population Imaging at Erasmus MC, Rotterdam
Learn more
HOPPR’s Medical-Grade Generalized Foundation Model enhances medical research and hypotheses while simplifying and lowering costs for data collection and training. AI Foundational Models are versatile, pre-trained architectures that serve as a starting point for customizing specific tasks through Fine-Tuned models, for which expertise in a particular domain is critical.
Join DeepHealth as we meet with leading radiologists and healthcare innovators at the Strategic 2025 Radiology Spring Summit. We are honored to be a part of this gathering and share our cutting-edge insights on emerging technologies, best practices, and future trends shaping the radiology landscape.
Los Angeles, CA/Somerville, MA, February 25, 2025 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT) and ConcertAI’s TeraRecon, a leader in medical imaging advanced visualization, clinical AI, and workflow automation, announced today a strategic collaboration to integrate certain capabilities to advance imaging tools and the radiology workflow.
Disclaimers:
DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please
contact us.